stock queery (Wockhardt)

balram · Jun 13, 2015

Minakshi ji, wockhardt can add in portfolio for long term and entry price adv me. wock fundamental describe in details?

Meenakshi Razdan · Jun 14, 2015

I have moved the post because it was posted in the wrong section.

Wockhardt has corrected quite steeply in the past few months over the lack of clarity relating to the problems with the USFDA. Even after the resolution of the problems, it could take another 12 to 18 months for the re-launch of the products in the US market.

You can the interview of Mr. Habib Khorakhiwala where he has explained the future prospects of the company.

The stock is also not cheap (~35x). Until the clarity emerges, the stock is likely to drift with no firm trend. I think there are a number of other Pharma companies that are worthy of consideration at this stage.

Md Jamil · Jun 15, 2015

Avoid it may come down to 850+ levels. Near to 850 it will be a good buy but time being stay away from WockPharma

balram · Jun 15, 2015

thanks for your adv wock

stockguru · Jun 16, 2015

Meenakshi Razdan said: ↑

I have moved the post because it was posted in the wrong section.

Wockhardt has corrected quite steeply in the past few months over the lack of clarity relating to the problems with the USFDA. Even after the resolution of the problems, it could take another 12 to 18 months for the re-launch of the products in the US market.

You can the interview of Mr. Habib Khorakhiwala where he has explained the future prospects of the company.

The stock is also not cheap (~35x). Until the clarity emerges, the stock is likely to drift with no firm trend. I think there are a number of other Pharma companies that are worthy of consideration at this stage.
Click to expand...

The last time they ran into trouble , I guess in 2013 the stock corrected heavily and quite steeply that time from around 2000 levels to around 400 . The stock is highly volatile and I agree with you that the risk reward ratio is not suitable to new investors at the moment

Log in

stock queery (Wockhardt)

balram New Member

Meenakshi Razdan Administrator Staff Member Moderator

Md Jamil New Member

balram New Member

stockguru Active Member

stock queery

Mukul Agrawal's portfolio has 56 stocks valued at ₹7,329 Cr in Dec'24 (vs ₹4,695 Cr in 2023, up +56%

Vijay Kedia's portfolio has 15 stocks valued at ₹1913 Cr in Dec'24 (vs ₹1476 Cr in 2023, +30%)

15 top High Dividend Yield stocks ranging from 4% to 25%

List of 12 Quality Stocks with high dividend yield from 3.2% to 10.9%.

Log in

stock queery (Wockhardt)

balram New Member

Meenakshi Razdan Administrator Staff Member Moderator

Md Jamil New Member

balram New Member

stockguru Active Member

stock queery

Mukul Agrawal's portfolio has 56 stocks valued at ₹7,329 Cr in Dec'24 (vs ₹4,695 Cr in 2023, up +56%

Vijay Kedia's portfolio has 15 stocks valued at ₹1913 Cr in Dec'24 (vs ₹1476 Cr in 2023, +30%)

15 top High Dividend Yield stocks ranging from 4% to 25%

List of 12 Quality Stocks with high dividend yield from 3.2% to 10.9%.

Useful Searches